Warren Buffett and IUDs?; FDA publishes FY16 device fees;

@FierceMedDev: ICYMI Friday: Upstart gets $6M to back the first FDA-cleared, OTC conception assistance device. Article | Follow @FierceMedDev

@VarunSaxena2: ResMed acquires China's Curative Medical to get bigger in sleep disorder devices. Item | Follow @VarunSaxena2

@EmilyWFierce: $OSUR got an FDA OK for emergency use of its rapid Ebola test. Press release | Follow @EmilyWFierce

> Bloomberg takes an in-depth look at the sizable role that billionaire Warren Buffett has played in the popularization of the IUD. Story

> The FDA has published its user fees for medical devices for fiscal 2016. More

> Covidien, now owned by Medtronic ($MDT), has asked the U.S. Supreme Court to take up a ruling against it that would require it to pay $176 million to the Ethicon unit of Johnson & Johnson ($JNJ) regarding violation of a surgical device patent. More

> The FDA may regulate an app for recently released OTC pain device Quell from micro-cap NeuroMetrix ($NURO). Story

Biotech News

@FierceBiotech: ICYMI Friday: Merck's Ebola vaccine is 100% successful in interim Phase III results. Report | Follow @FierceBiotech

@JohnCFierce: Is it just me, or is $SHPG's Ornskov overrated? Shire chief Ornskov bets $300M on another eye drug bolt-on buyout. Story | Follow @JohnCFierce

@DamianFierce: Charming addition to the drug co. nonsense lexicon: "biobetter." More | Follow @DamianFierce

> Sorrento buys into biosimilars with a Chinese antibody deal. Report

> Lexicon rockets up after a positive PhIII study sets up an NDA. Story

> AstraZeneca deepens its Isis ties with a $65M R&D pact. Article

Pharma News

@FiercePharma: ICYMI: Suit says CVS manipulated generic drug prices. Item | Follow @FiercePharma

@EricPFierce: As #Hospira expands recall of #ketorolac to 37M vials you've got to wonder what Pfizer thinks. Article | Follow @EricPFierce

@CarlyHFierce: #ICYMI Friday: Ackman's 'wolf pack' drove Allergan into foreign hands, former CEO says. More | Follow @CarlyHFierce

> Express Scripts stiff-arms AZ's Onglyza, Vivus' Qsymia with new 2016 formulary. Article

> Ex-Teva employee said she got canned for passing info to the feds in Latin America fraud probe. News

Animal Health News

> VCA ups 2015 guidance as Q2 sales and profits soar past expectations. More

> Heska doubles Q2 operating income but misses on revenue. Report

> Schein misses Q2 estimates on currency woes and sales challenges. Story

> IDEXX shares climb on record diagnostics placements and Q2 earnings gain. Article

> Report: 'Precision farming' set to revolutionize livestock care. More

Biotech IT News

> Y Combinator continues push into bioinformatics with investment in Cofactor Genomics. News

> NIH to bankroll initiatives to build Cancer Genomics Cloud Pilots into R&D programs. Report

> Ex-BGI CEO's next move? A $1.6B push to find a 'formula for life.' More

> First startups graduate from Illumina Accelerator as deadline for next phase nears. Story

> Venter's HLI plans to ramp up sequencing capacity as more pharma deals near fruition. Article

Pharma Marketing News

> Express Scripts kicks another batch of meds off its preferred formulary. Item

> Pfizer's hot-selling Ibrance gets even hotter with new $710M sales estimate for 2015. News

> Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode. Story

> Shyft Analytics: Targeted drugs need a data-fueled marketing shift. Article

> Can a dwindling rep tally keep Vivus' obesity med in the game? More

Suggested Articles

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years.